KESTRA MEDICAL TECHNOLOGIES, LTD. - KMTS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | T. Rowe Price Associates, Inc. | 7.5% | 4,369,429 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Endeavour Medtech Growth II LP | 4.2% | 2,448,942 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Endeavour Medtech Growth II Parallel LP | 4.2% | 2,448,942 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Endeavour Medtech II GP Limited | 4.2% | 2,448,942 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bain Charger Holdings, L.P. | 43.1% | 25,172,338 | View |
| Oct 07, 2025 | SCHEDULE 13G/A | FMR LLC | 10.2% | 5,225,988 | View |
| Oct 07, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 10.2% | 5,225,988 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.